ISPAD Clinical Practice Consensus Guidelines 2006?2007 The diagnosis and management of monogenic diabetes in children

2006 ◽  
Vol 7 (6) ◽  
pp. 352-360 ◽  
Author(s):  
Andrew Hattersley ◽  
Jan Bruining ◽  
Julian Shield ◽  
Pal Njolstad ◽  
Kim Donaghue
2018 ◽  
Vol 19 ◽  
pp. 47-63 ◽  
Author(s):  
Andrew T. Hattersley ◽  
Siri A. W. Greeley ◽  
Michel Polak ◽  
Oscar Rubio-Cabezas ◽  
Pål R. Njølstad ◽  
...  

2011 ◽  
Vol 7 (3) ◽  
pp. 225
Author(s):  
Gianfranco Sinagra ◽  
Michele Moretti ◽  
Giancarlo Vitrella ◽  
Marco Merlo ◽  
Rossana Bussani ◽  
...  

In recent years, outstanding progress has been made in the diagnosis and treatment of cardiomyopathies. Genetics is emerging as a primary point in the diagnosis and management of these diseases. However, molecular genetic analyses are not yet included in routine clinical practice, mainly because of their elevated costs and execution time. A patient-based and patient-oriented clinical approach, coupled with new imaging techniques such as cardiac magnetic resonance, can be of great help in selecting patients for molecular genetic analysis and is crucial for a better characterisation of these diseases. This article will specifically address clinical, magnetic resonance and genetic aspects of the diagnosis and management of cardiomyopathies.


BJS Open ◽  
2021 ◽  
Vol 5 (Supplement_1) ◽  
Author(s):  
Chan Hee Koh ◽  
Danyal Z Khan ◽  
Ronneil Digpal ◽  
Hugo Layard Horsfall ◽  
Hani J Marcus ◽  
...  

Abstract Introduction The clinical practice and research in the diagnosis and management of Cushing’s disease remains heterogeneous and challenging to this day. We sought to establish the characteristics of Cushing’s disease, and the trends in diagnosis, management and reporting in this field. Methods Searches of PubMed and Embase were conducted. Study protocol was registered a-priori. Random-effects analyses were conducted to establish numerical estimates. Results Our screening returned 159 papers. The average age of adult patients with Cushing’s disease was 39.3, and 13.6 for children. The male:female ratio was 1:3. 8% of patients had undergone previous transsphenoidal resection. The ratio of macroadenomas: microadenomas:imaging-undetectable adenomas was 18:53:29. The most commonly reported preoperative biochemical investigations were serum cortisol (average 26.4µg/dL) and ACTH (77.5pg/dL). Postoperative cortisol was most frequently used to define remission (74.8%), most commonly with threshold of 5µg/dL (44.8%). Average remission rates were 77.8% with recurrence rate of 13.9%. Median follow-up was 38 months. Majority of papers reported age (81.9%) and sex (79.4%). Only 56.6% reported whether their patients had previous pituitary surgery. 45.3% reported whether their adenomas were macroadenoma, microadenoma or undetectable. Only 24.1% reported preoperative cortisol, and this did not improve over time. 60.4% reported numerical thresholds for cortisol in defining remission, and this improved significantly over time (p = 0.004). Visual inspection of bubbleplots showed increasing preference for threshold of 5µg/dL. 70.4% reported the length of follow up. Conclusion We quantified the characteristics of Cushing’s disease, and analysed the trends in investigation and reporting. This review may help to inform future efforts in forming guidelines for research and clinical practice.


2014 ◽  
Vol 20 (4) ◽  
pp. 352-359 ◽  
Author(s):  
Mor Peleg ◽  
John Fox ◽  
Vivek Patkar ◽  
David Glasspool ◽  
Ioannis Chronakis ◽  
...  

2018 ◽  
Vol 20 (6) ◽  
pp. NP1-NP1

Samantha S Taylor, Andrew H Sparkes, Katherine Briscoe, Jenny Carter, Salva Cervantes Sala, Rosanne E Jepson, Brice S Reynolds and Brian A Scansen J Feline Med Surg 2017; 19: 288–303 Readers should note that the version of the guidelines that appeared in print in March 2017 and online until May 2018 has been amended. The version now appearing online is the correct one. For information, the following amendment has been made to the original published version. In Table 6 on page 299 the unit for esmolol should have been μg/kg/min and not mg/kg/min, as stated. The ‘Suggested dose’ column entry for esmolol has therefore been amended to ‘50–100 μg/kg/min CRI’.


2016 ◽  
Vol 57 (03) ◽  
pp. 118-125 ◽  
Author(s):  
YT Wang ◽  
CB Chee ◽  
LY Hsu ◽  
R Jagadesan ◽  
GJ Kaw ◽  
...  

1992 ◽  
Vol 45 (10) ◽  
pp. 943-944
Author(s):  
E Higgins ◽  
A Du Vivier

2009 ◽  
Vol 10 ◽  
pp. 33-42 ◽  
Author(s):  
Andrew Hattersley ◽  
Jan Bruining ◽  
Julian Shield ◽  
Pal Njolstad ◽  
Kim C Donaghue

2017 ◽  
Vol 51 (06) ◽  
pp. 270-271 ◽  
Author(s):  
Sara Baldelli ◽  
Emilio Clementi ◽  
Dario Cattaneo

AbstractThe updated AGNP Consensus Guidelines for Therapeutic Drug Monitoring (TDM) in Neuropsychopharmacology recently published in the journal have reinforced the key role of TDM to individualize psychoparmacological therapies in clinical practice. However, we believe, that these guidelines have missed the important opportunity to face with, and to provide useful information on, the emerging issue of long-acting injectable formulations of atypical antipsychotics. Specific therapeutic ranges also for these formulations should be included in the next AGNP guidelines.


Sign in / Sign up

Export Citation Format

Share Document